Merck lifts full-year forecast as Keytruda sales soar

Go back to Merck lifts full-year forecast as Keytruda sales soar
Merck & Co. (NYSE: MRK) Delayed: 119.60 +4.12 (3.57%)
Previous Close $115.48    52 Week High $65.46 
Open $116.53    52 Week Low $47.97 
Day High $119.80    P/E 81.36 
Day Low $116.53    EPS $1.47 
Volume 11,893,342